Trial to evaluate the efficacy of fluvastatin on certain markers

Trial Profile

Trial to evaluate the efficacy of fluvastatin on certain markers

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Dyslipidaemias
  • Focus Biomarker; Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 07 Nov 2011 Actual end date (1 Jun 2007) added as reported by ClinicalTrials.gov.
    • 21 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top